William Bonello
Stock Analyst at Craig-Hallum
(4.86)
# 350
Out of 4,407 analysts
277
Total ratings
61.5%
Success rate
26.1%
Average return
Main Sectors:
Stocks Rated by William Bonello
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Maintained: Buy | n/a | $59.92 | - | 31 | Jun 9, 2026 | |
| SOPH SOPHiA GENETICS | Maintained: Buy | n/a | $4.88 | - | 16 | Jun 8, 2026 | |
| SERA Sera Prognostics | Initiated Coverage: Buy | $6 | $1.87 | +220.86% | 1 | Jun 4, 2026 | |
| VCYT Veracyte | Maintained: Buy | n/a | $47.33 | - | 12 | May 22, 2026 | |
| PSNL Personalis | Maintained: Buy | n/a | $9.59 | - | 14 | May 20, 2026 | |
| MDXH MDxHealth | Maintained: Buy | $3 | $0.5422 | +453.30% | 11 | May 14, 2026 | |
| MYGN Myriad Genetics | Rated: Buy | $10 | $4.33 | +130.95% | 9 | May 6, 2026 | |
| QDEL QuidelOrtho | Maintained: Buy | n/a | $14.18 | - | 17 | May 5, 2026 | |
| ADPT Adaptive Biotechnologies | Maintained: Buy | n/a | $17.60 | - | 10 | May 5, 2026 | |
| SRTA Strata Critical Medical | Maintained: Buy | n/a | $5.43 | - | 3 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.16 | - | 13 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.56 | - | 15 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.15 | - | 18 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $22.97 | - | 30 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $4.67 | +114.13% | 6 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $224 | $212.07 | +5.63% | 18 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 | $131.62 | -5.03% | 21 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $26.62 | - | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.20 | - | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.74 | +187.36% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $280.49 | - | 2 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.64 | - | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.25 | n/a | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.97 | n/a | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.90 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.39 | n/a | 1 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $130.59 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.00 | n/a | 1 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $367.15 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $78.94 | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $15.00 | n/a | 1 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $14.90 | n/a | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $11.72 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.27 | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.15 | n/a | 1 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $6.50 | n/a | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $39.80 | n/a | 1 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.76 | n/a | 2 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $14.76 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $101.47 | n/a | 1 | Feb 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $56.71 | n/a | 1 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.65 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $20.76 | n/a | 1 | Apr 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.61 | n/a | 1 | Jan 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $203.06 | n/a | 1 | Sep 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $266.16 | n/a | 1 | Aug 28, 2013 |
GeneDx Holdings
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $59.92
Upside: -
SOPHiA GENETICS
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $4.88
Upside: -
Sera Prognostics
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $1.87
Upside: +220.86%
Veracyte
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $47.33
Upside: -
Personalis
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $9.59
Upside: -
MDxHealth
May 14, 2026
Maintained: Buy
Price Target: $3
Current: $0.5422
Upside: +453.30%
Myriad Genetics
May 6, 2026
Rated: Buy
Price Target: $10
Current: $4.33
Upside: +130.95%
QuidelOrtho
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $14.18
Upside: -
Adaptive Biotechnologies
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $17.60
Upside: -
Strata Critical Medical
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $5.43
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $15.16
Upside: -
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $2.56
Upside: -
Apr 29, 2026
Maintained: Buy
Price Target: n/a
Current: $11.15
Upside: -
Apr 29, 2026
Rated: Hold
Price Target: n/a
Current: $22.97
Upside: -
Mar 11, 2026
Rated: Buy
Price Target: $10
Current: $4.67
Upside: +114.13%
Mar 4, 2026
Maintained: Buy
Price Target: $224
Current: $212.07
Upside: +5.63%
Feb 20, 2026
Rated: Buy
Price Target: $125
Current: $131.62
Upside: -5.03%
Oct 29, 2025
Maintained: Buy
Price Target: n/a
Current: $26.62
Upside: -
Oct 23, 2025
Maintained: Buy
Price Target: n/a
Current: $5.20
Upside: -
Aug 18, 2025
Reiterated: Buy
Price Target: $5
Current: $1.74
Upside: +187.36%
Jun 27, 2025
Maintained: Buy
Price Target: n/a
Current: $280.49
Upside: -
Jun 25, 2025
Maintained: Buy
Price Target: n/a
Current: $37.64
Upside: -
May 5, 2025
Maintained: Buy
Price Target: n/a
Current: $16.25
Upside: n/a
Mar 10, 2025
Maintained: Buy
Price Target: n/a
Current: $17.97
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: n/a
Current: $6.90
Upside: n/a
Feb 19, 2025
Maintained: Buy
Price Target: n/a
Current: $23.39
Upside: n/a
Feb 12, 2025
Maintained: Buy
Price Target: n/a
Current: $130.59
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: n/a
Current: $29.00
Upside: n/a
Feb 6, 2025
Maintained: Buy
Price Target: n/a
Current: $367.15
Upside: n/a
Feb 4, 2025
Maintained: Hold
Price Target: n/a
Current: $78.94
Upside: n/a
Jan 31, 2025
Rated: Buy
Price Target: n/a
Current: $15.00
Upside: n/a
Jan 21, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $14.90
Upside: n/a
Jan 17, 2025
Maintained: Buy
Price Target: $21
Current: $11.72
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $4
Current: $1.27
Upside: n/a
Sep 18, 2024
Rated: Buy
Price Target: n/a
Current: $1.15
Upside: n/a
Sep 12, 2024
Rated: Buy
Price Target: $6
Current: $6.50
Upside: n/a
Aug 20, 2024
Rated: Buy
Price Target: n/a
Current: $39.80
Upside: n/a
Jul 9, 2024
Maintained: Buy
Price Target: n/a
Current: $2.76
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $14.76
Upside: n/a
Feb 13, 2017
Initiated Coverage: Buy
Price Target: $48
Current: $101.47
Upside: n/a
Nov 9, 2016
Downgraded: Hold
Price Target: n/a
Current: $56.71
Upside: n/a
Oct 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.65
Upside: n/a
Apr 9, 2015
Initiated Coverage: Buy
Price Target: $7
Current: $20.76
Upside: n/a
Jan 29, 2015
Downgraded: Hold
Price Target: n/a
Current: $26.61
Upside: n/a
Sep 19, 2013
Initiated Coverage: Buy
Price Target: $74
Current: $203.06
Upside: n/a
Aug 28, 2013
Initiated Coverage: Buy
Price Target: $116
Current: $266.16
Upside: n/a